Covid-19 Vaccine
FDA approves Moderna COVID-19 vaccine for some children
The FDA this week fully approved Moderna’s COVID-19 vaccine for children aged 6 months to 11 years but limited the approval to those with at least one underlying condition that puts them at risk for severe disease.
FDA approves its requested updated warning labels for COVID-19 vaccines
The FDA has approved its requested updated versions of expanded warning labels for COVID-19 vaccines.
FDA approves Moderna’s lower-dose COVID-19 vaccine for some
The FDA approved Moderna’s lower-dose COVID-19 vaccine, but only for individuals aged 65 years or older and people aged 12 to 64 years at high risk for severe disease, aligning with the agency’s new restrictions for COVID-19 shots.
Program delabels other drug allergies during COVID-19 vaccine evaluations
Practices can delabel other suspected drug allergies while assessing patients for allergies to COVID-19 vaccines, according to a study published in Vaccine.
CDC tweaks — but does not remove — COVID-19 vaccine recommendation for kids
The CDC tweaked — but did not remove — its recommendation for COVID-19 vaccination in children, days after HHS Secretary Robert F. Kennedy Jr. said the agency would stop recommending the shots for healthy kids and pregnant women.
Kennedy: CDC will stop recommending COVID shots for healthy children, pregnant women
HHS Secretary Robert F. Kennedy Jr. on Tuesday announced that the CDC will no longer recommend COVID-19 vaccines for healthy children and healthy pregnant women.
FDA committee recommends formula for fall COVID-19 vaccines
An FDA committee on Thursday recommended that COVID-19 vaccines for the 2025-2026 respiratory virus season — which, for the first time, will be limited to certain groups — target the JN.1 lineage of SARS-CoV-2.
FDA tells vaccine makers to expand warning labels on COVID-19 shots
The FDA has told vaccine manufacturers to expand the warning labels on their COVID-19 shots with more information about the risk for rare heart conditions following vaccination.
FDA will restrict future COVID-19 vaccines based on age, risk factors
FDA officials outlined new restrictions for COVID-19 vaccines that could limit their use in the United States.
FDA approves Novavax’s COVID-19 vaccine — with restrictions
The FDA has approved Novavax’s protein-based COVID-19 vaccine, giving some Americans another option besides messenger RNA vaccines to prevent SARS-CoV-2 infection.